| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 09/24/2003 | CN1443766A Method for preparing cis-1,3-dibenzylimidazoline-2-ketone-2H-furano [3,4-d] imidazol-2,4,6-triuetone (I) |
| 09/23/2003 | USRE38257 Piperdine derivatives and hypotensives containing the same |
| 09/23/2003 | US6624187 Long wave length absorbing bacteriochlorin alkyl ether analogs |
| 09/18/2003 | WO2003076938A1 Novel fluorescent label compounds |
| 09/18/2003 | WO2003076443A1 Spiro compounds with npy antagonistic activity |
| 09/18/2003 | WO2003076440A1 Condensed heterocyclic compounds as calcitonin agonists |
| 09/18/2003 | WO2003076424A1 Macrocyclic compounds useful as pharmaceuticals |
| 09/18/2003 | WO2003076398A2 Pyrrole-2, 5-dione derivatives and their use as gsk-3 inhibitors |
| 09/18/2003 | WO2003048122A3 Inhibitors of cytosolic phospholipase a2 |
| 09/18/2003 | WO2003022848A3 Process for the preparation of diketopyrrolopyrroles |
| 09/18/2003 | WO2003011851A3 Aromatic hydroxamic acid derivatives useful as hdac inhibitors |
| 09/18/2003 | WO2002034745A8 Chemokine receptor binding heterocyclic compounds |
| 09/18/2003 | US20030176702 N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease |
| 09/18/2003 | US20030176697 Such as 2-(methylsulfanyl)-6-(3,5-dimethyoxyphenyl)-8-ethyl-8H-pyrido(2,3-d) -pyrimidine-7-one; antitumor agents; calcium channel blockers |
| 09/18/2003 | US20030176520 4-cyanocoumarin derivatives and uses thereof |
| 09/18/2003 | US20030176476 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 09/18/2003 | US20030176464 Phenyl substituted 4-hydroxy tetrahydroxypyridone |
| 09/18/2003 | US20030176463 For therapy of disease states resulting from angiogenesis; can be administered orally |
| 09/18/2003 | US20030176454 N-coating heterocyclic compounds |
| 09/18/2003 | US20030176453 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor |
| 09/18/2003 | US20030176433 For therapy and prophylaxis of hepatitis C virus (HCV) infection |
| 09/18/2003 | US20030176432 Cyclic and heterocyclic N-substituted alpha-iminohydroxamic and -carboxylic acids |
| 09/18/2003 | US20030176430 For therapy and prophylaxis of Tachykinin-mediated diseases |
| 09/18/2003 | US20030176422 Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods |
| 09/18/2003 | US20030176370 Anti-viral pyrimidine nucleoside analogues |
| 09/18/2003 | US20030176324 Derivatives of water insoluble drugs which exhibit good activity and water solubility |
| 09/18/2003 | CA2482191A1 Spiro compounds with npy antagonistic activity |
| 09/18/2003 | CA2478110A1 Novel fluorescent label compounds |
| 09/18/2003 | CA2478065A1 Macrocyclic compounds useful as pharmaceuticals |
| 09/18/2003 | CA2477984A1 Pyrrole-2, 5-dione derivatives and their use as gsk-3 inhibitors |
| 09/17/2003 | EP1343827A1 N-alkoxy-4,4-dioxy-polyalkyl-piperidine compounds, their corresponding n-oxides and controlled radical polymerization therewith |
| 09/17/2003 | EP1343796A2 Compounds and methods |
| 09/17/2003 | EP1343789A1 Tricyclic derivatives of indole with antiangiogenic activity |
| 09/17/2003 | EP1343767A2 Synthesis of pancratistatin |
| 09/17/2003 | EP1343766A1 Cyclization process step in the making of quinolones and naphthyridines |
| 09/17/2003 | EP1343753A2 Antimicrobial agents |
| 09/17/2003 | EP1224174B1 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists |
| 09/17/2003 | EP1095021B1 Quinoline derivatives |
| 09/17/2003 | EP0706526B1 Photochromic compounds |
| 09/17/2003 | CN1443187A Fused cyclic compounds as modulators of nuclear hormone receptor function |
| 09/17/2003 | CN1121398C Alicyclic acylated heterocyclic derivatives |
| 09/17/2003 | CN1121391C Substituted 3-cyano quinolines |
| 09/17/2003 | CN1121376C Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives and matrix metalloprotease inhibitors |
| 09/16/2003 | US6620945 Squalene synthetase inhibitors; antilipemic agents, anticholesterol agents |
| 09/16/2003 | US6620937 Intermediates in the synthesis of camptothecin and related compounds and synthesis thereof |
| 09/16/2003 | US6620833 Coccidiosis treatment; 4,5-tetrafluoroethylenedioxybenzimidazole derivatives |
| 09/16/2003 | US6620822 Synergistic mixtures comprising 5,7-dichloro-4-(4-fluoro-phenoxy)-quinoline |
| 09/16/2003 | US6620546 Ionic composition comprising salt having conductivity of greater than 10-5 S.cm-1 between -30 and 150 degrees C; cation is proton, hydronium, hydroxonium, nitrosonium, ammonium or metal cation; anion is carbanion containing fluorine |
| 09/16/2003 | CA2231025C Novel compounds of 2-aminoindane, process for their preparation and pharmaceutical compositions containing them |
| 09/16/2003 | CA2047857C (quinolin-2-ylmethoxy)heterotetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes |
| 09/16/2003 | CA2046429C Imide derivatives, and their production and use |
| 09/12/2003 | WO2003075091A1 Colour photographic recording material |
| 09/12/2003 | WO2003074530A1 Bicyclic pyridine and pyrimidine p38 kinase inhibitors |
| 09/12/2003 | WO2003074527A1 Crystalline polymorphic form of irinotecan hydrochloride |
| 09/12/2003 | WO2003045942A3 Chemokine receptor antagonists and methods of use thereof |
| 09/12/2003 | WO2003034987A3 Androgen receptor modulators and methods of use thereof |
| 09/12/2003 | WO2002004443A3 Heterocycle carboxamides as antiviral agents |
| 09/12/2003 | WO2001083800A9 Heterologous production of polyketides |
| 09/12/2003 | CA2477926A1 Crystalline polymorphic form of irinotecan hydrochloride |
| 09/12/2003 | CA2477721A1 Bicyclic pyridine and pyrimidine p38 kinase inhibitors |
| 09/11/2003 | WO2003074046A1 Antidepressant |
| 09/11/2003 | US20030171600 Diaminofluorescein derivatives |
| 09/11/2003 | US20030171423 Enzyme inhibitor for treating HIV infections in mammals; viricides; patient is suffering from a multi-drug resistant HIV infection; AIDS therapy |
| 09/11/2003 | US20030171418 Pyranoindazoles and their use for the treatment of glaucoma |
| 09/11/2003 | US20030171394 Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers |
| 09/11/2003 | US20030171392 Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof |
| 09/11/2003 | US20030171219 2,4,5-trisubstituted phenylketo-enols for use as pesticides and herbicides |
| 09/11/2003 | US20030170831 Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
| 09/10/2003 | EP1342723A1 Indole derivatives and use thereof in medicines |
| 09/10/2003 | EP1341769A2 Bacterial gyrase inhibitors and uses thereof |
| 09/10/2003 | EP1341763A2 N-alkoxy-4,4-dioxy-polyalkyl-piperidine compounds, with glycidyl or alkylcarbonyl groups as functional initiators for controlled radical polymerization |
| 09/10/2003 | EP1341761A1 SUBSTITUTED INDOLES, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH INDOLES AND THEIR USE AS PPAR-$g(g) BINDING AGENTS |
| 09/10/2003 | EP1341540A2 Tyrosine kinase inhibitors |
| 09/10/2003 | CN1441805A Antitumoral analogue of Et-743 |
| 09/10/2003 | CN1440973A Optical pure analog of camptothecine |
| 09/10/2003 | CN1440972A Optical pure synthetic intermediate of camptothecine and its preparing method |
| 09/09/2003 | US6617452 Liquid-liquid extraction being carried out in the first stage at a pH-value of about 4; treating narrow-angle glaucoma, Alzheimer's disease, as well as alcohol and nicotine dependence. |
| 09/09/2003 | US6617437 Modified oligonucleotide of given formula; useful in diagnostics and therapeutics |
| 09/09/2003 | US6617335 Multi-drug resistance reversal activities; sensitivity enhancers in cancer chemotherapy. |
| 09/09/2003 | US6617327 For therapy of depression and other diseases such as obsessive compulsive disorder, panic attacks, generalized anxiety disorder, social anxiety disorder, sexual dysfunction, eating disorders, obesity, addictive disorders |
| 09/09/2003 | CA2183155C Naphthylisoquinoline alkaloids, pharmaceutical compositions containing them and their use for the treatment of malaria |
| 09/09/2003 | CA2138026C Novel 1,4-dihydroquinoxaline-2,3-diones and uses therefor as glycine receptor antagonists |
| 09/04/2003 | WO2003072569A1 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases |
| 09/04/2003 | WO2003072566A1 Fused tricyclic heterocycles useful for treating hyper-proliferative disorders |
| 09/04/2003 | WO2003072561A1 Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders |
| 09/04/2003 | WO2003072027A2 Compositions and formulations of 9- nitrocamptothecin polymorphs and methods of use thereof |
| 09/04/2003 | WO2003062209A3 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin |
| 09/04/2003 | WO2003047505A3 Topoisomerase poison agents |
| 09/04/2003 | WO2003045313A3 2-aminoquinoline compounds |
| 09/04/2003 | WO2002068387A8 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 09/04/2003 | US20030166935 Spiroazabicyclic heterocyclic compounds |
| 09/04/2003 | US20030166929 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 09/04/2003 | US20030166693 Benzene derivatives and pharmaceutical use thereof |
| 09/04/2003 | US20030166690 Use of compounds for decreasing activity of hormone-sensitive |
| 09/04/2003 | US20030166689 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 09/04/2003 | US20030166671 Amorphous polymorphic forms by grinding or pulverizing; having a distinctive X-ray powder diffraction pattern; anti-tumor and -carcinogenic agents; administered by mouth, intravenous injection and inhalation |
| 09/04/2003 | US20030166650 E.g., 3-(2-fluorophenyl)-N-(1-(3-morpholin-4-yl)phenyl)-propyl)acrylamide; disorders responsive to opening of KCNQ potassium channels; analgesics; migraine, bipolar disorders, anticonvulsants, antiepileptic, anxiolytic agents |
| 09/04/2003 | US20030166649 E.g., 4-(2-(1-Benzhydryl-2-(2-((benzylsulfonyl)amino)ethyl)-5-chloro-1H-indol-3 -yl)ethoxy)benzoic acid; inhibitors of phospholipase enzymes, esp. phospholipase A2; antiarthritic and -inflammatory agents; analgesics; rheumatoid diseases |
| 09/04/2003 | US20030166644 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 09/04/2003 | US20030166641 Heterocyclic amines such as 1-(3,4-methylenedioxyphenyl)-2-(5 -(3,4-dimethoxyphenyl)pyrimidin-2-yl)- 2,3,4,9-tetrahydro-1H-beta-carboline, used as enzyme inhibitors for prophylaxix of sexual disorders |